The demand for the drug has soared in recent weeks following more people contracting the fungal infection. Liposomal amphotericin B injection is indicated for mucormycosis, also known as Black Fungus. Following the approval, AmphoTLC will be imported from Taiwan by Stelis Biopharma, the biotech arm of Strides group, and launched and distributed in India immediately, a release said. We have expanded our COVID-19 portfolio further with the TLC partnership.”TLC appreciates the support of Indian authorities who “thoroughly and expeditiously approved AmphoTLC,” said its founder, chairman and CEO Keelung Hong. Shipments of the drug to India will begin immediately, he said.

Source: The Hindu May 27, 2021 17:42 UTC